Researchers in California are about to start the first FDA-sanctioned clinical trial of a stem cell treatment for a brain disease.

Stem Cells Inc. will test the safety of injecting fetal-derived neural stem cells into the brains of children suffering from a rare and always fatal disorder known as Batten disease.